comparemela.com
Home
Live Updates
Study 19 - Breaking News
Pages:
Latest Breaking News On - Study 19 - Page 1 : comparemela.com
Advanced Ovarian Cancer: Current Treatment Landscape in Second- and Later-Line Settings
Expert oncologists review the current PARP inhibitor treatment indications for patients with advanced ovarian cancer and discuss how to best manage patients who have been impacted by the recent updates to the PARP inhibitors.
Advanced ovarian cancer treatment
Recent updates
Later line maintenance settings
Ovarian cancer
Current treatment landscape
Advanced ovarian cancer
Recurrent advanced ovarian cancer
Study 19
Nova trial
Ariel 3
Nccn guidelines
Platinum chemotherapy
vimarsana © 2020. All Rights Reserved.